152 related articles for article (PubMed ID: 25920711)
1. Radioiodine therapy increases the risk of cerebrovascular events in hyperthyroid and euthyroid patients.
la Cour JL; Jensen LT; Vej-Hansen A; Nygaard B
Eur J Endocrinol; 2015 Jun; 172(6):771-8. PubMed ID: 25920711
[TBL] [Abstract][Full Text] [Related]
2. Radioiodine Therapy Does Not Change the Atherosclerotic Burden of the Carotid Arteries.
la Cour JL; Andersen UB; Sørensen CH; Nygaard B; Jensen LT
Thyroid; 2016 Jul; 26(7):965-71. PubMed ID: 27117943
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose].
Bakker SC; Zanin DE; Zweers EJ
Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1837-41. PubMed ID: 12382370
[TBL] [Abstract][Full Text] [Related]
4. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results].
Giovanella L; De Palma D; Ceriani L; Vanoli P; Garancini S; Tordiglione M; Tarolo GL
Radiol Med; 2000 Dec; 100(6):480-3. PubMed ID: 11307510
[TBL] [Abstract][Full Text] [Related]
5. High prevalence of side effects after recombinant human thyrotropin-stimulated radioiodine treatment with 30 mCi in patients with multinodular goiter and subclinical/clinical hyperthyroidism.
Romão R; Rubio IG; Tomimori EK; Camargo RY; Knobel M; Medeiros-Neto G
Thyroid; 2009 Sep; 19(9):945-51. PubMed ID: 19678745
[TBL] [Abstract][Full Text] [Related]
6. Dosimetry and risk estimates of radioiodine therapy for large, multinodular goiters.
Huysmans DA; Buijs WC; van de Ven MT; van den Broek WJ; Kloppenborg PW; Hermus AR; Corstens FH
J Nucl Med; 1996 Dec; 37(12):2072-9. PubMed ID: 8970537
[TBL] [Abstract][Full Text] [Related]
7. Development of hypothyroidism during long-term follow-up of patients with toxic nodular goitre after radioiodine therapy.
Kahraman D; Keller C; Schneider C; Eschner W; Sudbrock F; Schmidt M; Schicha H; Dietlein M; Kobe C
Clin Endocrinol (Oxf); 2012 Feb; 76(2):297-303. PubMed ID: 21854403
[TBL] [Abstract][Full Text] [Related]
8. Thyroid function and mortality in patients treated for hyperthyroidism.
Franklyn JA; Sheppard MC; Maisonneuve P
JAMA; 2005 Jul; 294(1):71-80. PubMed ID: 15998893
[TBL] [Abstract][Full Text] [Related]
9. Radioiodine treatment of hyperthyroidism-prognostic factors for outcome.
Allahabadia A; Daykin J; Sheppard MC; Gough SC; Franklyn JA
J Clin Endocrinol Metab; 2001 Aug; 86(8):3611-7. PubMed ID: 11502786
[TBL] [Abstract][Full Text] [Related]
10. Radioiodine treatment of hyperthyroidism in patients with low thyroid uptake.
Ruchała M; Sowiński J; Dolata M; Junik R; Gembicki M; Skiba A
Nucl Med Rev Cent East Eur; 2005; 8(1):28-32. PubMed ID: 15977144
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcome of radioiodine treatment of hyperthyroidism: a follow-up study.
Berg G; Michanek A; Holmberg E; Nyström E
J Intern Med; 1996 Feb; 239(2):165-71. PubMed ID: 8568485
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular Morbidity and Mortality After Treatment of Hyperthyroidism with Either Radioactive Iodine or Thyroidectomy.
Ryödi E; Metso S; Huhtala H; Välimäki M; Auvinen A; Jaatinen P
Thyroid; 2018 Sep; 28(9):1111-1120. PubMed ID: 29882483
[TBL] [Abstract][Full Text] [Related]
13. Increased cardiovascular and cancer mortality after radioiodine treatment for hyperthyroidism.
Metso S; Jaatinen P; Huhtala H; Auvinen A; Oksala H; Salmi J
J Clin Endocrinol Metab; 2007 Jun; 92(6):2190-6. PubMed ID: 17374710
[TBL] [Abstract][Full Text] [Related]
14. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism.
Franklyn JA; Daykin J; Holder R; Sheppard MC
QJM; 1995 Mar; 88(3):175-80. PubMed ID: 7767667
[TBL] [Abstract][Full Text] [Related]
15. [Therapeutic results of radioiodine therapy of hyperthyroid thyroid gland diseases].
Debrand-Passard A; Barzen G; Richter W; Wenzel KW; Felix R
Med Klin (Munich); 1994 Jun; 89(6):319-23. PubMed ID: 8072455
[TBL] [Abstract][Full Text] [Related]
16. Cancer Incidence and Mortality in Patients Treated Either With RAI or Thyroidectomy for Hyperthyroidism.
Ryödi E; Metso S; Jaatinen P; Huhtala H; Saaristo R; Välimäki M; Auvinen A
J Clin Endocrinol Metab; 2015 Oct; 100(10):3710-7. PubMed ID: 26262435
[TBL] [Abstract][Full Text] [Related]
17. Increased Cardiovascular Mortality and Morbidity in Patients Treated for Toxic Nodular Goiter Compared to Graves' Disease and Nontoxic Goiter.
Giesecke P; Rosenqvist M; Frykman V; Friberg L; Wallin G; Höijer J; Lönn S; Törring O
Thyroid; 2017 Jul; 27(7):878-885. PubMed ID: 28471268
[TBL] [Abstract][Full Text] [Related]
18. Long term efficacy of radioiodine treatment in hyperthyroidism.
Bakos B; Takács I; Nagy Z; Kósa JP; Balla B; Tóbiás B; Halászlaki C; Szili B; Lakatos P
Exp Clin Endocrinol Diabetes; 2013 Aug; 121(8):494-7. PubMed ID: 23934676
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
[TBL] [Abstract][Full Text] [Related]
20. Comparison of mortality in hyperthyroidism during periods of treatment with thionamides and after radioiodine.
Boelaert K; Maisonneuve P; Torlinska B; Franklyn JA
J Clin Endocrinol Metab; 2013 May; 98(5):1869-82. PubMed ID: 23543662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
